María Luisa Cagigal

Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors

Juan Carlos Rodríguez-Duque, José Luís Calleja, Paula Iruzubieta et al. · Clinical Gastroenterology and Hepatology · 2022 · 68 citations · Full text

Medicine, Internal Medicine, Pathology +13

Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)

Lucía Lavín-Alconero, Tatiana Fernández-Lanas, Paula Iruzubieta et al. · Trials · 2021 · 29 citations · Full text

Medicine, Clinical Sciences, Surgery +15

Beneficial effect of ursodeoxycholic acid in patients with acyl‐CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia

Marta Alonso‐Peña, Ricardo A. Espinosa-Escudero, Elisa Herráez et al. · Hepatology · 2022 · 21 citations · Full text

Life Sciences, Biochemistry, Molecular Medicine +16

Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain

José Ignacio Fortea, Antonio Cuadrado, Ángela Puente et al. · Journal of Clinical Medicine · 2020 · 13 citations · Full text

Medicine, Infectious Diseases, Surgery +17

Anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma presenting as a bladder neoplasm

María Luisa Cagigal, J. Fernando Val‐Bernal · Pathology International · 2008 · 10 citations

Medicine, Oncology, Pathology +17